Cargando…

Gomesin peptides prevent proliferation and lead to the cell death of devil facial tumour disease cells

The Tasmanian devil faces extinction due to devil facial tumour disease (DFTD), a highly transmittable clonal form of cancer without available treatment. In this study, we report the cell-autonomous antiproliferative and cytotoxic activities exhibited by the spider peptide gomesin (AgGom) and gomesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez-Rojo, Manuel A., Deplazes, Evelyne, Pineda, Sandy S., Brust, Andreas, Marth, Tano, Wilhelm, Patrick, Martel, Nick, Ramm, Grant A., Mancera, Ricardo L., Alewood, Paul F., Woods, Gregory M., Belov, Katherine, Miles, John J., King, Glenn F., Ikonomopoulou, Maria P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841354/ https://www.ncbi.nlm.nih.gov/pubmed/29531816 http://dx.doi.org/10.1038/s41420-018-0030-0

Ejemplares similares

Gomesin inhibits melanoma growth by manipulating key signaling cascades that control cell death and proliferation
por: Ikonomopoulou, Maria P., et al.
Publicado: (2018)

The Biological and Biophysical Properties of the Spider Peptide Gomesin
por: Tanner, John D., et al.
Publicado: (2018)

The antiproliferative and apoptotic profile of gomesin against DFTD
por: Ikonomopoulou, Maria P., et al.
Publicado: (2018)

Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils
por: Tovar, Cesar, et al.
Publicado: (2017)

Tasmanian devil cathelicidins exhibit anticancer activity against Devil Facial Tumour Disease (DFTD) cells
por: Petrohilos, Cleopatra, et al.
Publicado: (2023)

Identification of dendritic cells, B cell and T cell subsets in Tasmanian devil lymphoid tissue; evidence for poor immune cell infiltration into devil facial tumors
por: Howson, Lauren J., et al.
Publicado: (2014)

Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils
por: Pye, Ruth, et al.
Publicado: (2016)

Resistance to Degradation and Cellular Distribution are Important Features for the Antitumor Activity of Gomesin
por: Buri, Marcus V., et al.
Publicado: (2013)

New Insights into the Role of MHC Diversity in Devil Facial Tumour Disease
por: Lane, Amanda, et al.
Publicado: (2012)

Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release
por: Pye, Ruth, et al.
Publicado: (2018)

Vincristine Chemotherapy Trials and Pharmacokinetics in Tasmanian Devils with Tasmanian Devil Facial Tumor Disease
por: Phalen, David N., et al.
Publicado: (2013)

The Devil's Advocate
por: Woods, Caspian
Publicado: (2013)

Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease
por: Tovar, Cesar, et al.
Publicado: (2018)

Challenges of an Emerging Disease: The Evolving Approach to Diagnosing Devil Facial Tumour Disease
por: Espejo, Camila, et al.
Publicado: (2021)

Isotopic niche variation in Tasmanian devils Sarcophilus harrisii with progression of devil facial tumor disease
por: Bell, Olivia, et al.
Publicado: (2021)

A designed cyclic analogue of gomesin has potent activity against Staphylococcus aureus biofilms
por: Dias, Susana A, et al.
Publicado: (2022)

Unlocking the Potential of the Antimicrobial Peptide Gomesin: From Discovery and Structure–Activity Relationships to Therapeutic Applications
por: Liu, Xiaorong, et al.
Publicado: (2023)

ERK and mTORC1 Inhibitors Enhance the Anti-Cancer Capacity of the Octpep-1 Venom-Derived Peptide in Melanoma BRAF(V600E) Mutations
por: Moral-Sanz, Javier, et al.
Publicado: (2021)

Inducible IFN-γ Expression for MHC-I Upregulation in Devil Facial Tumor Cells
por: Ong, Chrissie E. B., et al.
Publicado: (2019)

The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines
por: Patchett, Amanda L., et al.
Publicado: (2016)

Cathelicidins in the Tasmanian devil (Sarcophilus harrisii)
por: Peel, E., et al.
Publicado: (2016)

Variants in the host genome may inhibit tumour growth in devil facial tumours: evidence from genome-wide association
por: Wright, Belinda, et al.
Publicado: (2017)

Identification of candidate genes for devil facial tumour disease tumourigenesis
por: Taylor, Robyn L., et al.
Publicado: (2017)

The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease
por: Kosack, Lindsay, et al.
Publicado: (2019)

The Tasmanian devil microbiome—implications for conservation and management
por: Cheng, Yuanyuan, et al.
Publicado: (2015)

Revisiting the Interaction of Melittin with Phospholipid Bilayers: The Effects of Concentration and Ionic Strength
por: Sabapathy, Thiru, et al.
Publicado: (2020)

Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease
por: Flies, Andrew S., et al.
Publicado: (2017)

Allorecognition in the Tasmanian Devil (Sarcophilus harrisii), an Endangered Marsupial Species with Limited Genetic Diversity
por: Kreiss, Alexandre, et al.
Publicado: (2011)

How the devil facial tumor disease escapes host immune responses
por: Siddle, Hannah V, et al.
Publicado: (2013)

Global DNA Methylation patterns on marsupial and devil facial tumour chromosomes
por: Ingles, Emory D., et al.
Publicado: (2015)

Influence of force field choice on the conformational landscape of rat and human islet amyloid polypeptide
por: Moore, Sandra J., et al.
Publicado: (2022)

Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours
por: Ong, Chrissie E. B., et al.
Publicado: (2022)

Mouse Model of Devil Facial Tumour Disease Establishes That an Effective Immune Response Can be Generated Against the Cancer Cells
por: Pinfold, Terry L., et al.
Publicado: (2014)

A Devil of a Transmissible Cancer
por: Woods, Gregory M., et al.
Publicado: (2020)

The devil /
por: Molnár, Ferenc, 1878-1952
Publicado: (1908)

Expression of the Nonclassical MHC Class I, Saha-UD in the Transmissible Cancer Devil Facial Tumour Disease (DFTD)
por: Hussey, Kathryn, et al.
Publicado: (2022)

The devils = (The possessed) /
por: Dostoyevsky, Fyodor, 1821-1881

Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii)
por: Ujvari, Beata, et al.
Publicado: (2016)

Devil Driving. Panchoa Devils—Classed as "Silent" and "Crying"
por: Bagchi, K. P.
Publicado: (1914)

The devil is in the details: Genomics of transmissible cancers in Tasmanian devils
por: Storfer, Andrew, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q263vvejamav1rjk3efqjm139e